REDWOOD CITY, Calif.--(BUSINESS WIRE)--Gynesonics, Inc., a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, today announced the recent publication and presentation of results from the Symptom Effectiveness Study of VizAblate® Intrauterine Ultrasound-Guided Radiofrequency Ablation (IUUSgRFA) in the Ablation of Uterine Fibroids (FAST-EU). Fifty patients were treated at seven centers across The Netherlands, the UK and Mexico.
Help employers find you! Check out all the jobs and post your resume.
